Updates are available New edition dated 2022-06-30

Click to view New edition: https://doi.org/10.37871/jbres1504

Development of a Novel Anti-SARS-CoV-2 Antiviral: Effective Inhibitory Activity of Brilacidin

Crossref DOI link: https://doi.org/10.37871/jbres1504

Published Online: 2022-06

Update policy: https://doi.org/10.37871/jbres.policy

About CrossMark